Bausch Health
BHC
#4132
Rank
HK$21.69 B
Marketcap
HK$58.50
Share price
0.13%
Change (1 day)
1.54%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): HK$7.57

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is HK$7.57. In 2024 the company made an earnings per share (EPS) of -HK$0.94 an increase over its 2023 EPS that were of -HK$12.64.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$7.57-908.94%
2024-HK$0.94-92.59%
2023-HK$12.64160.89%
2022-HK$4.84-76.64%
2021-HK$20.7368.45%
2020-HK$12.31-68.91%
2019-HK$39.58-57.11%
2018-HK$92.30-272.22%
2017HK$53.59-199.29%
2016-HK$53.97798.7%
2015-HK$6.01-128.31%
2014HK$21.22-204.62%
2013-HK$20.28602.7%
2012-HK$2.89

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
-HK$7.41-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-HK$1.87-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA